Literature DB >> 12962033

[Chemokines and chemokine receptors in multiple sclerosis].

Tatsuro Misu1, Kazuo Fujihara, Yasuto Itoyama.   

Abstract

Findings of chemokines and chemokine receptors in multiple sclerosis(MS) are reviewed. MS is a T-helper type 1 (Th1) dominant condition, and Th1-associated chemokine receptors(CCR5 and CXCR3) on CD4- and CD8-positive T cells and their ligands are upregulated in the CNS of the patients with active disease. Meanwhile, Th2-associated chemokine receptors(CCR3 and CCR4) on CD4- and CD8-positive T cells are suppressed during relapse. Their expressions are useful immunological measures of disease activity, clinical subtypes and therapy. CCR7 and the ligands are expressed in the CNS of MS and may be important for the recruitment of immune cells committed to immunological memory and antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962033

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

2.  PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cells.

Authors:  Joseph Barbi; Hannah E Cummings; Bao Lu; Steve Oghumu; Thomas Rückle; Christian Rommel; William Lafuse; Caroline C Whitacre; Abhay R Satoskar
Journal:  Blood       Date:  2008-07-24       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.